MedPath

FRAGMIN

FRAGMIN

Approved
DIN Number

02231171

Drug Class

Human

Market Date

Nov 27, 1997

Company
HC

Pfizer Canada Ulc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02231171
AIG Number0126861002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AB04 DALTEPARIN
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous ,  Intravenous
AHFS Classification20:12.04.16
Health Canada Classification

ACTIVE INGREDIENTS (1)

DALTEPARIN SODIUMActive
Strength: 25000 UNIT / ML
Monograph: DALTEPARIN SODIUM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.